Bedaquiline
Indication :
- Multidrug resistant Tuberculosis
Dosing :
>12 years:
First 2 weeks 400 mg/day. Week 3-24: 200 mg 3 times/week.
Adverse Effect :
Nausea, arthralgia, headache, elevated transaminases, QT prolongation.
Hepatic Dose :
No dosage adjustments are recommended in mild to moderate hepatic impairment. Bedaquiline has not been studied in patients with severe hepatic impairment.
Pediatric Oncall
06/23/2025 18:54:15
06/23/2025 18:54:15
Bedaquiline